Skip Navigation

Nephrology Dialysis Transplantation 2007 22(Supplement 2):ii22-ii44; doi:10.1093/ndt/gfm019
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kooman, J.
Right arrow Articles by Vanholder, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kooman, J.
Right arrow Articles by Vanholder, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

EBPG guideline on haemodynamic instability

Jeroen Kooman1, Ali Basci2, Francesco Pizzarelli3, Bernard Canaud4, Patrick Haage5, Denis Fouque6, Klaus Konner7, Alejandro Martin-Malo8, Luciano Pedrini9, James Tattersall10, Jan Tordoir11, Marianne Vennegoor12, Christoph Wanner13, Piet ter Wee14 and Raymond Vanholder15

1Department of Internal Medicine, division of Nephrology, University Hospital Maastricht, The Netherlands, 2Department of Medicine; division of Nephrology, Ege University Medical Faculty, Izmir, Turkey, 3Nephrology Unit, SM Annunziata Hospital, Florence, Italy, 4Nephrology, Dialysis and Intensive Care Unit, Lapeyronie University Hospital, Montpellier, France, 5Department of Diagnostic and Interventional Radiology, Helios Klinikum Wuppertal, University Hospital Witten/Herdecke, Germany, 6Département de Néphrologie JE 2411-Dénutrition des Maladies Chroniques, Hôpital E Herriot, France, 7Medical Faculty University of Cologne, Medicine Clinic I, Hospital Merheim, Germany (retired), 8Nephrology Department, Reina Sofia University Hospital, Cordoba, Spain, 9Division of Nephrology and Dialysis, Bolognini Hospital, Seriate, Italy, 10Department of Renal Medicine, St. James's University Hospital, Leeds, UK, 11Department of Surgery, University Hospital Maastricht, The Netherlands, 12Department of Nephrology, Nutrition and Dietetics, Guy's and St Thomas’ NHS Foundation Trust, London, UK (retired), 13Department of Medicine, Division of Nephrology, University Hospital, Würzburg, Germany, 14Department of Nephrology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands, and 15Nephrology Section, Department of Internal Medicine, University Hospital, Ghent, Belgium

Correspondence and offprint requests to: Jeroen P. Kooman, MD, PhD, Department of Internal Medicine, Division of Nephrology, University Hospital Maastricht, PO Box 5800 6202 AZ Maastricht, The Netherlands. Email: jkoo@sint.azm.nl

Outline

Introduction

Definition of intra-dialytic hypotension (IDH)

Incidence of IDH

Relation between IDH and outcome

Patients at risk for IDH

Pathophysiology of IDH

Prevention of IDH

1. Evaluation of the patient

1.1 Assessment of dry weight

1.2 Measurement of blood pressure and heart rate during dialysis

1.3 Cardiac evaluation

2. Lifestyle interventions

2.1 Sodium restriction

2.2 Food and caffeine intake during dialysis

3. Factors relation to the dialysis treatment

3.1 Manipulation of ultrafiltration

3.1.1 Ultrafiltration profiling

3.1.2 Blood volume controlled ultrafiltration

3.2 Dialysate composition

3.2.1 High sodium dialysis and sodium profiling

3.2.2 Dialysate buffer

3.2.3 Dialysate calcium

3.2.4 Other components of dialysate

3.3 Dialysis membranes/contamination of dialysate

3.4 Dialysate temperature

3.5 Convective techniques and isolated ultrafiltration

3.5.1 Convective techniques

3.5.2 Isolated ultrafiltration

3.6 Dialysis duration and frequency

3.7 Switch to peritoneal dialysis

4. Antihypertensive drugs and preventive medication

4.1 Antihypertensive drugs

4.2 Preventive vasoactive agents

4.3 Carnitine

5. Stratified approach to prevent IDH

6. Treatment of IDH

6.1 Trendelenburg position

6.2 Stopping ultrafiltration

6.3 Infusion fluids

6.4 Protocol

Keywords: dialysis; guideline; haemodynamic; hypotension; instability

The first 150 words of the full text of this article appear below.



   Introduction
 
Definition of intra-dialytic hypotension
In the literature, the definition of intra-dialytic hypotension (IDH) is not standardized and differs between various studies. Most definitions however, take into account either a relative or an absolute decline in blood pressure (BP) as well as the presence of specific symptoms. Although no evidence based recommendation regarding the definition of IDH can be given, the EBPG working group stresses that both a reduction in BP, as well as clinical symptoms with need for nursing intervention should be present in order to accept the presence of IDH. Moreover, the definition of IDH should ideally be equal in the literature and different treatment guidelines. Conforming to the K/DOQI guidelines, a proposed definition is a decrease in systolic BP ≥20 mmHg or a decrease in mean arterial pressure (MAP) by 10 mmHg associated with clinical events and need for nursing interventions.

Incidence of IDH
In reviews, a 20% incidence of intra-dialytic hypotension is widely cited . . . [Full Text of this Article]



   References
 
Relation between IDH and outcome


   References
 
Patients at risk for IDH


   References
 
Pathophysiology of IDH


   References
 


   Prevention of IDH
 
1. Evaluation of the patient
Rationale
Recommendations for research


   References
 
Rationale
Recommendations for research


   References
 
Rationale
Recommendation for research


   References
 


   2. Lifestyle interventions
 
Rationale
Recommendations for research


   References
 
Rationale
Recommendations for research


   References
 


   3. Factors related to the dialysis treatment
 
3.1 Optimizing ultrafiltration: ultrafiltration profiling and blood volume controlled ultrafiltration
Rationale
Recommendations for research


   References
 
Rationale
Recommendation for research


   References
 


   3.2 Dialysate composition
 
3.2.1 Dialysate sodium
Rationale
Recommendation for research


   References
 


   3.2.2 Dialysate buffer
 
Rationale
Recommendations for research


   References
 


   3.2.3 Dialysate calcium
 
Rationale
Recommendations for research


   References
 


   3.2.4 Other dialysate components
 
Rationale
Recommendations for research


   References
 


   3.3 Dialysis membranes and contamination of dialysate
 
Rationale
Recommendations for research


   References
 


   3.4 Dialysate and body temperature
 
Rationale
Recommendations for research


   References
 


   3.5 Convective techniques and isolated ultrafiltration
 
Rationale
Recommendation for research


   References
 
Rationale
Recommendation for research


   References
 


   3.6 Dialysis duration and frequency
 
Rationale
Recommendation for research


   References
 


   3.7 Switch to peritoneal dialysis
 
Rationale
Recommendations for research


   4. Avoidance of antihypertensive drugs and prescription of vasoactive medication before dialysis
 
Rationale
Recommendation for research


   References
 
Rationale
Recommendations for research


   References
 
Recommendations of research


   References
 


   5. Stratified approach to prevent IDH
 
First-line approach
Second-line approach
Third-line approach (only if other treatment options have failed)


   6. Treatment of IDH
 
6.1 Trendelenburg position
Rationale
Recommendation for research
6.2 Stopping ultrafiltration
Rationale
Recommendation for research
6.3 Infusion fluids
Rationale
Summary of evidence
Recommendation for research
6.4 Protocol-based treatment
Rationale
Recommendation for research


   Reference
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. Machek, T. Jirka, U. Moissl, P. Chamney, and P. Wabel
Guided optimization of fluid status in haemodialysis patients
Nephrol. Dial. Transplant., September 30, 2009; (2009) gfp487v1.
[Abstract] [Full Text] [PDF]


Home page
NDT PlusHome page
P. Ponce, P. Taborsky, and J. Vlasak
Assessment and Reduction of fluid overload using a body composition monitor
NDT Plus, June 3, 2009; (2009) sfp063v1.
[Full Text] [PDF]


Home page
NDT PlusHome page
R. Vanholder, D. Abramowicz, J. B. Cannata-Andia, V. Cocchi, P. Cochat, A. Covic, K.-U. Eckardt, D. Fouque, O. Heimburger, S. Jenkins, et al.
The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP)
NDT Plus, June 1, 2009; 2(3): 213 - 221.
[Full Text] [PDF]


Home page
CJASNHome page
F. M. van der Sande, G. Wystrychowski, J. P. Kooman, L. Rosales, J. Raimann, P. Kotanko, M. Carter, C. T. Chan, K. M.L. Leunissen, and N. W. Levin
Control of Core Temperature and Blood Pressure Stability during Hemodialysis
Clin. J. Am. Soc. Nephrol., January 1, 2009; 4(1): 93 - 98.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Zoccali, D. Abramowicz, J. B Cannata-Andia, P. Cochat, A. Covic, K.-U. Eckardt, D. Fouque, O. Heimburger, A. McLeod, E. Lindley, et al.
European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP)
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2162 - 2166.
[Full Text] [PDF]